Investment in Canada’s domestic pharmaceutical infrastructure is essential to ensure that the country has a “secure and consistent supply of prescription medicines,” the Canadian Generic Pharmaceutical Association has urged. The call comes as part of a “blueprint” document published by the body that also insists that an enhanced international role is needed for Canada, as well as engagement with manufacturers to create a local stockpile of essential drugs.
In the document, titled “Blueprint for a Sustainable Supply of Prescription Medicines for Canadians,” the CGPA says Canada’s pharmaceutical...